Identifying the Presence of Prostate Cancer in Individuals with PSA Levels <20 ng ml−1 Using Computational Data Extraction Analysis of High Dimensional Peripheral Blood Flow Cytometric Phenotyping Data-Reference-Cited by-同舟云学术

Identifying the Presence of Prostate Cancer in Individuals with PSA Levels <20 ng ml−1 Using Computational Data Extraction Analysis of High Dimensional Peripheral Blood Flow Cytometric Phenotyping Data

Published:2017-12-18 Issue: Volume:8 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Cosma Georgina,McArdle Stéphanie E.,Reeder Stephen,Foulds Gemma A.,Hood Simon,Khan Masood,Pockley A. Graham

Funder

Leverhulme Trust

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference27 articles.

1. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate;Stamey;N Engl J Med,1987

2. Detection of prostate cancer via biopsy in the Medicare seer population during the PSA era;Welch;J Natl Cancer Inst,2007

3. The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer;Norberg;Urology,1997

4. A prospective randomized trial comparing 6 versus 12 prostate biopsy cores: impact on cancer detection;Naughton;J Urol,2000

5. Prostate cancer detection rate and the importance of premalignant lesion in rebiopsy;Aganovic;Med Arh,2011

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Neutrosophic Cubic Hesitant Fuzzy Decision Support System, Application in the Diagnosis and Grading of Prostate Cancer;Fractal and Fractional;2022-11-04

2. Cancer Prediction using Machine Learning;2022 2nd International Conference on Innovative Practices in Technology and Management (ICIPTM);2022-02-23

3. Prostate Cancer: Early Detection and Assessing Clinical Risk Using Deep Machine Learning of High Dimensional Peripheral Blood Flow Cytometric Phenotyping Data;Frontiers in Immunology;2021-12-16

4. Quantification and Optimization of Standard-of-Care Therapy to Delay the Emergence of Resistant Bone Metastatic Prostate Cancer;Cancers;2021-02-08

5. Identifying prostate cancer and its clinical risk in asymptomatic men using machine learning of high dimensional peripheral blood flow cytometric natural killer cell subset phenotyping data;eLife;2020-07-28